Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is already a covered benefit for Medicare patients. Read the press release below, and learn more on the American Cancer Society’s Cancer Action Network website. Read the legislation here. *For insured … Read More
Professor spearheads pharmacogenomics learning program for pharmacists
Professor David Kisor saw a need for more pharmacogenomic education for pharmacists, and he wanted to fill it. Dr. Kisor, PharmD, serves as professor and chair of pharmaceutical sciences at Manchester University’s Pharmacy Program, in Fort Wayne, Ind. He’s long been interested in the field of pharmacogenomics, or how individual genetic differences affect drug response, and has written extensively on … Read More
Study: Pharmacogenomic knowledge gaps persist among physicians
More work seems needed to better familiarize physicians with the concept of pharmacogenomic testing, according to the results of a recent study. The study in the August edition of Pharmacogenomics and Personalized Medicine found that just 12.6 percent of the 300 physicians surveyed strongly or somewhat agreed with the question, “How familiar are you with pharmacogenomics?” Study authors Johansen Taber and Dickinson report this study gels with past research on … Read More